Evidence map›Paper›PMID 41547680›Full record

ArticleEJNMMI radiopharmacy and chemistry2026

Quality control of actinium-225 and

Miguel Toro-Gonzalez, Luke Wheeless, Vijai Kumar Reddy Tangadanchu, Cory Hawkins, Shannon Provo, William Smith, Michael Hommen, Dan DeVries, Jim Harvey, Tyler Drum and 1 more

Abstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miguel Toro-GonzalezNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Luke WheelessNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Vijai Kumar Reddy TangadanchuNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Cory HawkinsNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Shannon ProvoNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
William SmithNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Michael HommenNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Dan DeVriesNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Jim HarveyNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Tyler DrumNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA.
Diane S AbouNorthStar Medical Radioisotopes, LLC Research and Development, 1800 Gateway Boulevard, Beloit, WI, 53511, USA. dabou@northstarnm.com.ORCID http://orcid.org/0000-0002-3005-9623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActinium-225 radiopharmaceuticals have drawn great interest in cancer therapy due to their tumor-specific delivery of cytotoxic alpha-particles. Quality control (QC) is critical for these potent agents and there is currently no consensus for best practice of actinium-225 QC. Detection of actinium-225 (T

resultsThe plastic silicon scanner resulted in RCY% differences between 30 min and > 5 h evaluations, whereas the gas-filled proportional counter, when varying voltages, showed minor differences. Similarly, HPGe-TLC demonstrated equivalent RCY% between both equilibria. The NaI(Tl), LSC- TLC, and HPLC-gamma counting significantly underestimated RCY% or RCP% at 30 min. Considering gamma well counting LOQ and

conclusionFive instruments have been tested for their linearity, sensitivity, accuracy and specificity to actinium-225 quantification using francium-221 and bismuth-213 equilibria. Francium-221 equilibrium was deemed acceptable for TLC RCY% using HPGe and gas-filled proportional counter. Gamma well counting, LSC, and plastic silicon detector required bismuth-213 equilibrium for accurate RCY%. Low content free actinium-225 impurity was accurately reported for all methods except for the silicon detector. Overall, this investigation sheds light on the appropriate analytical methods for

Indexed as

Actinium-225 quality controlGamma well countingHigh purity germaniumHPLCLiquid scintillationThin layer chromatography

Identifiers

PMID41547680
PMCPMC12819953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.